Manufacturing Capabilities
MS Pharma has an established track record of manufacturing across a wide range of dosage forms. All our manufacturing sites are GMP accredited.
MS Pharma’s Global Production Network Comprises 4 Sites:
- Algeria: Our Site in Algeria is a center of excellence for development and manufacture of solid dose, liquid, and cream formulations for OTC and Rx products. It is the largest pharmaceutical manufacturing facility in Algeria.
- Jordan, Steriles: Our sterile site in Jordan has capability in asceptic, terminal, and lyophilized vial production, Large volume parenteral, and Pre filled syringe production. It is the only such site in the country.
- Jordan, Non-Steriles: Our non-sterile manufacturing site has a range of capabilities. It is a development and manufacturing site for solid dose, cephalosporins, liquids, creams, soft gelatine capsules, and solid dose products.
- Saudi Arabia: In Saudi, we have a packaging facility currently under construction.
Our Manufacturing Capabilities Include a Variety of Dosage Forms:
- Tablets, capsules, and oral dispersible manufacturing and packaging
- High potency tablets and capsules
- Sterile aseptic solution vials
- Freeze-dried vials
- LVP’s and Ampoules
- Sterile high potency vials
- Semi solids and liquids
- Soft gelatin capsules
- Multi-layer tablets
- Cephalosporins
- Shampoos
- Creams and liquids
MS Pharma’s dedicated R&D team has significant experience in formulation and analytical development, process development, and scale-up of various dosage forms.
MS Pharma has manufacturing sites in five countries in the MENA region and Europe.
